Pharmacokinetics, pharmacodynamics, and safety of administering pegylated recombinant megakaryocyte growth and development factor to newborn rhesus monkeys

被引：0
|
作者：
Sola, MC
Christensen, RD
Hutson, AD
Tarantal, AF
机构：
[1] Univ Florida, Gainesville, FL USA
[2] Calif Reg Primate Res Ctr, Davis, CA USA
来源：
PEDIATRIC RESEARCH | 1999年 / 45卷 / 04期
关键词：
D O I：
10.1203/00006450-199904020-01575
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
1558
引用
收藏
页码：265A / 265A
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics, pharmacodynamics, and safety of administering pegylated recombinant megakaryocyte growth and development factor to newborn rhesus monkeys
    Sola, MC
    Christensen, RD
    Hutson, AD
    Tarantal, AF
    PEDIATRIC RESEARCH, 2000, 47 (02) : 208 - 214
  • [2] Pharmacokinetics, Pharmacodynamics, and Safety of Administering Pegylated Recombinant Megakaryocyte Growth and Development Factor to Newborn Rhesus Monkeys
    Martha C Sola
    Robert D Christensen
    Alan D Hutson
    Alice F Tarantal
    Pediatric Research, 2000, 47 : 208 - 208
  • [3] Pharmacokinetics, Pharmacodynamics, and Safety of Administering Pegylated Recombinant Megakaryocyte Growth and Development Factor to Newborn Rhesus Monkeys
    Martha C Sola
    Robert D Christensen
    Alan D Hutson
    Alice F Tarantal
    Pediatric Research, 1999, 45 : 265 - 265
  • [4] Pharmacokinetics of PEGylated recombinant human endostatin in rhesus monkeys
    Guo, Lifang
    Li, Zuogang
    Xu, Benshan
    Yu, Min
    Fu, Yan
    Liu, Lihong
    Wang, Junzhi
    Luo, Yongzhang
    LIFE SCIENCES, 2019, 238
  • [5] Pharmacokinetics of pegylated recombinant human megakaryocyte growth and development factor in healthy volunteers and patients with hematological disorders
    Tanaka, H
    Takama, H
    Arai, Y
    Azuma, J
    Ohno, R
    Ikeda, Y
    Mizoguchi, H
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (04) : 269 - 279
  • [6] Pegylated recombinant human megakaryocyte growth and development factor suppresses the development of megakaryoblastic leukemia in mice
    Shibuya, K
    Kuwaki, T
    Akahori, H
    Kato, T
    Miyazaki, H
    LEUKEMIA RESEARCH, 2004, 28 (09) : 941 - 946
  • [7] PEGylated recombinant human megakaryocyte growth and development factor suppresses the development of megakaryoblastic leukemia in mice.
    Shibuya, K
    Akahori, H
    Tahara, E
    Kato, T
    Miyazaki, H
    BLOOD, 1997, 90 (10) : 757 - 757
  • [8] Pharmacokinetics of Subcutaneous Single Doses of Pegylated Recombinant Human Growth Hormone(PEG-rhGH)in rhesus Monkeys
    Cai, Yong M.
    Li, M.
    Zhang, Zong P.
    Chen, Zheng M.
    Liu, Chang X.
    DRUG METABOLISM REVIEWS, 2010, 42 : 269 - 269
  • [9] Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura
    Nomura, S
    Dan, K
    Hotta, T
    Fujimura, K
    Ikeda, Y
    BLOOD, 2002, 100 (02) : 728 - 730
  • [10] PHARMACOKINETICS AND PHARMACODYNAMICS OF RECOMBINANT HUMAN INTERLEUKIN-12 IN MALE RHESUS-MONKEYS
    NADEAU, RR
    OSTROWSKI, C
    NIWU, G
    LIBERATO, DJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1995, 274 (01): : 78 - 83
12345